Contact   |   Login
Careers Banner Image

Career Opportunities

Pharmapex Group adheres to a policy of equal opportunity employment. Employees and applicants for employment will not be discriminated against on the basis of race, color, religion, age, gender, national origin, sexual orientation, gender identity characteristics or expression, citizenship status, marital status, disability, veteran status or any other legally protected status, in any employment decisions, including, but not limited to, recruitment, hiring, compensation, training, apprenticeship, promotion, demotion, transfer, layoff, termination, and any other term and condition of employment. All employment-related decisions are based solely on relevant criteria, including training, experience, education, qualifications, abilities and suitability.

Our group embraces the core values of teamwork, honesty, courtesy and respect. Our prospective employees will enjoy working in a friendly, cooperative atmosphere that encourages individual growth and provides ample opportunity for advancement through on-the-job training and experience.

We are always looking for outstanding candidates to join our company. While we prefer experienced applicants, we encourage resume submissions by new candidates with demonstrated records of academic achievement. Our employment opportunities in particular involve challenging and at the same time rewarding positions in our Sales, Marketing, Business Development, and Logistics departments.

To share your CV and discuss matching skills, prospective candidates are encouraged to submit their resumes and accompanying cover letters to careers@PharmapexUSA.com. The information you submit to us will be treated as strictly confidential.



Quick Contact

Press Releases and Selected News:
Deferoxamine Mesylate Market to Witness Robust Expansion by 2029 with Teva api, Chengdu Easton Biopharmaceuticals, Pharmapex Group
The Deferoxamine Mesylate Report is a unique record that gives a total judgment of the market in terms of future patterns, development factors, creation volume, CAGR estimation, net revenue, cost, and industry-approved market data.

Pharmapex's novel mastitis treatment offers hope to world farmers
Efficient feed-based mastitis treatment boosts livestock health with a unique microencapsulated technology.

FDA approves Farxiga to treat type 2 diabetes
The U.S. FDA today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
© , Pharmapex USA, A member of Apex Group of Companies, All Rights Reserved.